ID

41075

Description

Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT01371630

Lien

https://clinicaltrials.gov/show/NCT01371630

Mots-clés

Versions (1)
  1. 19/06/2020 19/06/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

19 juin 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia NCT01371630

Anglais

Eligibility Leukemia NCT01371630

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01371630
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients age 60 years or older with previously untreated all of pre-b, philadelphia chromosome (ph-) negative all. minimal prior therapy (less than 1 week of steroids, vincristine, and/or 1 dose of anthracycline or alkylating agents) are allowed.
Description

Age | Pre B-cell acute lymphoblastic leukemia Untreated | Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Prior Therapy Minimal | Steroids | Vincristine | Anthracyclines | Alkylating Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0349636
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C4289946
UMLS CUI [4,1]
C1514463
UMLS CUI [4,2]
C0547040
UMLS CUI [5]
C0038317
UMLS CUI [6]
C0042679
UMLS CUI [7]
C0282564
UMLS CUI [8]
C0002073
2. zubrod performance status 0-3.
Description

Zubrod Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C3714786
3. adequate liver function (bilirubin </= 1.5 mg/dl and sgpt or sgot </= 3 x upper limit of normal [uln], unless considered due to tumor), and renal function (creatinine </= 2 mg/dl). even if organ function abnormalities are considered due to tumor, the upper limit for bilirubin is </= 2.0 mg/dl and creatinine </= 3 mg/dl.
Description

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Exception Due to Neoplasm | Renal function | Creatinine measurement, serum | Organ function Abnormality Due to Neoplasm

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0678226
UMLS CUI [5,3]
C0027651
UMLS CUI [6]
C0232804
UMLS CUI [7]
C0201976
UMLS CUI [8,1]
C0678852
UMLS CUI [8,2]
C1704258
UMLS CUI [8,3]
C0678226
UMLS CUI [8,4]
C0027651
4. provision of written informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
5. patients in first remission are eligible.
Description

Remission First

Type de données

boolean

Alias
UMLS CUI [1,1]
C0544452
UMLS CUI [1,2]
C0205435
6. patients with refractory-relapsed all of any age are eligible, provided they are not eligible for regimens of higher priority. currently study 2012-0151 (inotuzumab vs. intensive chemotherapy in all salvage 1 and 2) is an fda pivotal trial and is a higher priority (september 10, 2012).
Description

Refractory acute lymphoid leukemia | Acute lymphocytic leukemia recurrent | Age | Ineligibility Clinical Trial High priority

Type de données

boolean

Alias
UMLS CUI [1]
C4302097
UMLS CUI [2]
C1504403
UMLS CUI [3]
C0001779
UMLS CUI [4,1]
C1512714
UMLS CUI [4,2]
C0008976
UMLS CUI [4,3]
C1273516
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. ph-positive all, burkitt's leukemia or lymphoma, t-cell all or lymphoblastic lymphoma.
Description

Philadelphia positive acute lymphocytic leukaemia | Burkitt Lymphoma | T-ALL | Lymphoblastic Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2]
C0006413
UMLS CUI [3]
C1961099
UMLS CUI [4]
C0855146
2. patient with active heart disease (nyha class >/= 3 as assessed by history and physical examination).
Description

Heart Disease New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
3. patients with a cardiac ejection fraction (as measured by either muga or echocardiogram) < 40% are excluded.
Description

Cardiac ejection fraction MUGA scan | Cardiac ejection fraction Echocardiography

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0521317
UMLS CUI [2,1]
C0232174
UMLS CUI [2,2]
C0013516
4. patients with active hepatitis are excluded.
Description

Hepatitis

Type de données

boolean

Alias
UMLS CUI [1]
C0019158
5. pregnant or breast-feeding women are excluded.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Leukemia NCT01371630

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01371630
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age | Pre B-cell acute lymphoblastic leukemia Untreated | Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Prior Therapy Minimal | Steroids | Vincristine | Anthracyclines | Alkylating Agents
Item
1. patients age 60 years or older with previously untreated all of pre-b, philadelphia chromosome (ph-) negative all. minimal prior therapy (less than 1 week of steroids, vincristine, and/or 1 dose of anthracycline or alkylating agents) are allowed.
boolean
C0001779 (UMLS CUI [1])
C0349636 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C4289946 (UMLS CUI [3])
C1514463 (UMLS CUI [4,1])
C0547040 (UMLS CUI [4,2])
C0038317 (UMLS CUI [5])
C0042679 (UMLS CUI [6])
C0282564 (UMLS CUI [7])
C0002073 (UMLS CUI [8])
Zubrod Performance Status
Item
2. zubrod performance status 0-3.
boolean
C3714786 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Exception Due to Neoplasm | Renal function | Creatinine measurement, serum | Organ function Abnormality Due to Neoplasm
Item
3. adequate liver function (bilirubin </= 1.5 mg/dl and sgpt or sgot </= 3 x upper limit of normal [uln], unless considered due to tumor), and renal function (creatinine </= 2 mg/dl). even if organ function abnormalities are considered due to tumor, the upper limit for bilirubin is </= 2.0 mg/dl and creatinine </= 3 mg/dl.
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0678226 (UMLS CUI [5,2])
C0027651 (UMLS CUI [5,3])
C0232804 (UMLS CUI [6])
C0201976 (UMLS CUI [7])
C0678852 (UMLS CUI [8,1])
C1704258 (UMLS CUI [8,2])
C0678226 (UMLS CUI [8,3])
C0027651 (UMLS CUI [8,4])
Informed Consent
Item
4. provision of written informed consent.
boolean
C0021430 (UMLS CUI [1])
Remission First
Item
5. patients in first remission are eligible.
boolean
C0544452 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
Refractory acute lymphoid leukemia | Acute lymphocytic leukemia recurrent | Age | Ineligibility Clinical Trial High priority
Item
6. patients with refractory-relapsed all of any age are eligible, provided they are not eligible for regimens of higher priority. currently study 2012-0151 (inotuzumab vs. intensive chemotherapy in all salvage 1 and 2) is an fda pivotal trial and is a higher priority (september 10, 2012).
boolean
C4302097 (UMLS CUI [1])
C1504403 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C1512714 (UMLS CUI [4,1])
C0008976 (UMLS CUI [4,2])
C1273516 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Philadelphia positive acute lymphocytic leukaemia | Burkitt Lymphoma | T-ALL | Lymphoblastic Lymphoma
Item
1. ph-positive all, burkitt's leukemia or lymphoma, t-cell all or lymphoblastic lymphoma.
boolean
C4524071 (UMLS CUI [1])
C0006413 (UMLS CUI [2])
C1961099 (UMLS CUI [3])
C0855146 (UMLS CUI [4])
Heart Disease New York Heart Association Classification
Item
2. patient with active heart disease (nyha class >/= 3 as assessed by history and physical examination).
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Cardiac ejection fraction MUGA scan | Cardiac ejection fraction Echocardiography
Item
3. patients with a cardiac ejection fraction (as measured by either muga or echocardiogram) < 40% are excluded.
boolean
C0232174 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
Hepatitis
Item
4. patients with active hepatitis are excluded.
boolean
C0019158 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
5. pregnant or breast-feeding women are excluded.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial